Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus

Fertility and Sterility

Volumn 86, Issue 2, 2006, Pages 405-410

  Kelestimur, Fahrettin ^a   Unluhizarci, Kürşad ^a   Baybuga, Hür ^a   Atmaca, Hulusi ^b   Bayram, Fahri ^a   Şahin, Yilmaz ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; BUSERELIN; FOLLITROPIN; GLUCOSE; HYDROXYPROGESTERONE; LUTEINIZING HORMONE; PRASTERONE SULFATE; PROLACTIN; PROSTAGLANDIN E2; SEX HORMONE BINDING GLOBULIN; THYROXINE;

ADULT; AGE DISTRIBUTION; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC PATIENT; DIET RESTRICTION; FEMALE; FOLLITROPIN BLOOD LEVEL; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; HIRSUTISM; HORMONE BLOOD LEVEL; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MENSTRUATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; ORGAN SIZE; OVARY POLYCYSTIC DISEASE; OVARY SIZE; PREMENOPAUSE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSTAGLANDIN BLOOD LEVEL; SAMPLE SIZE; SCORING SYSTEM; THYROTROPIN BLOOD LEVEL; UNIVERSITY HOSPITAL;

ADULT; BUSERELIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLICLE STIMULATING HORMONE; HIRSUTISM; HUMANS; LUTEINIZING HORMONE; OVARY; POLYCYSTIC OVARY SYNDROME; PREMENOPAUSE; PREVALENCE; SEX HORMONE-BINDING GLOBULIN;

EID: 33746354990     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.01.019     Document Type: Article

References (27)

1. Franks S. Polycystic ovary syndrome. N Engl J Med 333 (1995) 853-861
2. Unluhizarci{dotless} K., Kelestimur F., Bayram F., Şahin Y., and Tutuş A. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome. Clin Endocrinol 51 (1999) 231-236
3. Dunaif A. Insulin resistance and polycystic ovary syndrome. Endocr Rev 18 (1997) 774-800
4. Chang R.J., Nakamura R.M., Judd H.L., and Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57 (1983) 356-359
5. Ovalle F., and Azziz R. Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus. Fertil Steril 77 (2002) 1095-1105
6. Unluhizarci K., Çolak R., Şahin Y., Bayram F., and Kelestimur F. The prevalence of glucose intolerance in women with polycystic ovary syndrome. Turk J Endocrinol Metab 4 (2000) 135-137
7. Hatch R., Rosenfield R.L., Kim M.H., and Tredway D. Hirsutism. implications, etiology and management. Am J Obstet Gynecol 140 (1981) 815-830
8. Sahin Y., and Kelestimur F. 17-hydroxyprogesterone response to buserelin testing in the polycystic ovary syndrome. Clin Endocrinol 39 (1993) 151-155
9. Zawadzki J.K., and Dunaif A. Diagnostic criteria for polycystic ovary syndrome. towards a rational approach. In: Dunaif A., Givens J.R., Haseltine F., and Merriam G.R. (Eds). Polycystic ovary syndrome (1992), Blackwell Scientific, Boston (MA) 377-384
10. Adams J., Polson D.W., Abdulwahid N., Morris D.W., Franks S., Mason H.D., et al. Multifollicular ovaries. clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet (1985) 1375-1378
11. Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81 (2004) 19-25
12. Orsini L.F., Venturoli S., Lorusso R., Pluchinotta V., Paradisi R., and Bovicelli L. Ultrasound findings in polycystic ovarian disease. Fertil Steril 43 (1985) 709-714
13. Peppard H.R., Iuorno M.J., Marfpri J., and Nestler J.E. Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes. Diab Care 24 (2001) 1050-1052
14. Zargar H.A., Gupta V.K., Wani A.I., Masoodi S.R., Bashir M.I., Laway B.A., et al. Prevalance of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus. Reprod Biol Endocrinol 3 (2005) 35-41
15. Escobar-Morreale H.F., Roldan B., Barrio R., Alonso M., Sancho J., de la Calle H., et al. High prevalence of the polycystic ovary syndrome and hirsutism in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 85 (2000) 4182-4187
16. Asuncion M., Calvo R.M., San Millan J.L., Sancho J., Avila S., and Escobar-Morreale H.F. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. J Clin Endocrinol Metab 85 (2000) 2434-2438
17. South S.A., Asplin C.M., Carlsen E.C., Booth Jr. R.A., Weltman J.Y., Johnson M.L., et al. Alterations in luteinizing hormone secretory activity in women with insulin-dependent diabetes mellitus and secondary amenorrhea. J Clin Endocrinol Metab 76 (1993) 1048-1053
18. Corio V., Volpi R., Capretti L., Speroni G., Castelli A., and Chiodera P. Luteinizing hormone responses to gonadotrophin-releasing hormone and naloxone in menstruating women with type 1 diabetes mellitus of different duration. Fertil Steril 55 (1991) 712-716
19. Kopp H.P., Festa A., Krugluger W., and Schernthaner G. Low levels of sex-hormone binding globulin predict insulin requirement in patients with gestational diabetes mellitus. Exp Clin Endocrinol Diab 109 (2001) 365-369
20. Thadhani R., Wolf M., Hsu-Blatman K., Sandler L., Nathan D., and Ecker J.L. First-trimester sex hormone binding globulin and subsequent gestational diabetes mellitus. Am J Obstet Gynecol 189 (2003) 171-176
21. Barkai L., and Tombacz A. Alterations in insulin-like growth factor binding protein-1 and sex hormone binding globulin levels in type 1 diabetic adolescents with microalbuminuria. Diab Care 24 (2001) 605-606
22. Stamataki K.E., Spina J., Rangou D.B., Chlouverakis C.S., and Piaditis G.P. Ovarian function in women with noninsulin dependent diabetes mellitus. Clin Endocrinol 45 (1996) 615-621
23. Polson D.W., Wadsworth J., Adams J., and Franks S. Polycystic ovaries-a common finding in normal women. Lancet 1 (1988) 870-872
24. Clayton R.N., Ogden V., Hodgkinson J., Worsick L., Rodin D.A., Dyer S., et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population?. Clin Endocrinol 37 (1992) 127-134
25. Sadhukhan M., Atiomo W.U., and Dubbins P. Polycystic ovary syndrome. Where are we now?. J Women Image 4 (2002) 21-30
26. Holte J., Gennarelli G., Wide L., Lithell H., and Barne C. High prevalence of polycystic ovaries and associated clinical, endocrine and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab 83 (1998) 1143-1150
27. Conn J.J., Jacobs H.S., and Conway G.S. The prevalence of polycystic ovaries in women with type 2 diabetes mellitus. Clin Endocrinol 52 (2000) 81-86